Dr. Ben Galyardt told Newsweek: "There is no drug that will treat fatty liver. There is no surgery that will fix it." ...

A new malaria vaccine achieves an unparalleled 89% efficacy by targeting late-liver-stage antigens, unlocking new horizons in ...

Salk scientists have tracked the flow of trans fats using mouse models to describe the molecular mechanisms that cause trans fats to promote atherosclerotic cardiovascular disease (ASCVD), explaining ...

Controlling the dissolved oxygen in bioreactors sets the stage for developing new treatments for liver disease.

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

The most severe kidney damage is also known as end stage renal disease. Nowadays, there are lots of medications for people with diabetes. Diabetes drugs that have been shown to reduce chronic ...

Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the ... the approved anti-fibrotic (IPF) drug Pirfenidone and has been shown to inhibit in vitro both p38γ kinase ...

The FDA has rejected the supplemental new drug application for Ocaliva, a treatment for primary biliary cholangitis, a rare liver disease. In a letter issued to Intercept Pharmaceuticals ...

The FDA in 2016 granted accelerated approval to the FXR agonist as a second-line treatment for adults with PBC, either in ...

Trimetazidine should not be used in patients with history of kidney disease, patients allergic to the drug, and patients with Parkinson disease, restless leg syndrome or other movement disorders.

Health groups and patient advocates are raising concerns over patent monopolies on rare disease drugs in India. They argue that these monopolies, like the one held by Roche for the spinal muscular ...